Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why Submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Transparent Process
Open Access

Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response

View ORCID ProfileDanique Beijer, Thomas Agnew, View ORCID ProfileJohannes Gregor Matthias Rack, View ORCID ProfileEvgeniia Prokhorova, Tine Deconinck, Berten Ceulemans, Stojan Peric, Vedrana Milic Rasic, Peter De Jonghe, View ORCID ProfileIvan Ahel  Correspondence email, View ORCID ProfileJonathan Baets  Correspondence email
Danique Beijer
1Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
2Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Roles: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danique Beijer
Thomas Agnew
3Sir William Dunn School of Pathology, Oxford University, Oxford, UK
Roles: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Gregor Matthias Rack
3Sir William Dunn School of Pathology, Oxford University, Oxford, UK
Roles: Data curation, Formal analysis, Investigation, Methodology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johannes Gregor Matthias Rack
Evgeniia Prokhorova
3Sir William Dunn School of Pathology, Oxford University, Oxford, UK
Roles: Investigation, Methodology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evgeniia Prokhorova
Tine Deconinck
1Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
2Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Roles: Investigation, Methodology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berten Ceulemans
4Department of Pediatric Neurology, Antwerp University Hospital, Antwerp, Belgium
Roles: Data curation, Formal analysis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stojan Peric
5Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Roles: Data curation, Formal analysis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vedrana Milic Rasic
6Clinic for Neurology and Psychiatry for Children and Youth, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Roles: Data curation, Formal analysis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter De Jonghe
1Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
2Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
7Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Antwerp, Belgium
Roles: Data curation, Formal analysis, Supervision, Funding acquisition
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan Ahel
3Sir William Dunn School of Pathology, Oxford University, Oxford, UK
Roles: Conceptualization, Formal analysis, Supervision, Funding acquisition, Methodology, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivan Ahel
  • For correspondence: ivan.ahel@path.ox.ac.uk
Jonathan Baets
1Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
2Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
7Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Antwerp, Belgium
Roles: Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Baets
  • For correspondence: Jonathan.Baets@uantwerpen.be
Published 3 September 2021. DOI: 10.26508/lsa.202101057
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Autosomal recessive inheritance of ADPRHL2 mutations in two hereditary motor neuropathy families.

    Pedigrees of families A and B with their respective mutation and the segregation of each by genotype, showing affected (black), unaffected (white). The patient and the partially affected parent (grey) in family B, both carry a known causal EXT1 variant causal for their exostosis phenotype. The father does not present with the hereditary motor neuropathy and neurodevelopmental phenotype.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. In vitro expression and activity of ARH3 (mutant) protein and ribbon representation of ARH3 in complex with ADP ribosylation (yellow) and Mg2+ ions (dark blue).

    (A) SDS–PAGE analysis of expression and purification of recombinant ARH3 wild type and mutants in Escherichia coli. ARH3 (theoretical Mw 42.88 kD) was enrich from whole cell lysate by nickel affinity chromatography (for details, see the Materials and Methods section). Both C26F and V335G show similar expression, but lower abundance in the soluble fraction, compared with WT and D77N D778N mutant. (B) Alpha-helix 1, containing Cys26, is highlighted for orientation purposes. Right panels: Van der Waals radii of Cys26 sulphur and Val335 side chain carbon atoms are depicted as transparent spheres. Residue Cys26 is located in the core of a conserved helical bundle (right upper panel). Positioning of this residue within the structure suggest that the increase in Van der Waals volume associated with the C26F mutation incompatible with correct packing. Residue Val335 is located in partial structured surface loop packing against α-helix 1 (right lower panel) and is inserted in a hydrophobic pocket. The structural consequences of the V335G mutation are not immediately appreciable but may weaken the local packing, expose hydrophobic residues and thus affect the overall structural stability of the protein. Note that in the right panels foreground structural elements have been removed to allow representation of the buried residue pockets. Image was created with PyMOL v2.3 (Schrodinger LLC) using human ARH3 in complex with ADP-ribose (PDB 6D36). (C) The (ADP-ribosyl)hydrolase activity of ARH3 WT and mutants was assessed using H3 and poly(ADP-ribose)polymerase (PARP)1 MARylated and PARylated, respectively, in presence of 32P-NAD+ as substrates. After the reaction samples were analyzed by autoradiogram and SDS–PAGE. Both WT and V335G were active under the assay conditions. cntr (control; no ARH3).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Protein expression in control, C26F and V335G patient fibroblast cells.

    (A, B, C) Whole-cell lysates of patient-derived and control (cntr: healthy individual) fibroblast immunoblotted for ARH3 and GAPH (loading control) for the different mutations V335G (family A), C26F (family B) (B) soluble and insoluble whole-cell lysate fractions of patient and control fibroblasts immunoblotted for ARH3 and α-tubulin (loading control) (C) subcellular fractions of patient and control fibroblasts immunoblotted for α-tubulin (cytosolic control), VDAC1 (mitochondrial control) and Histone H3 (H3) (nuclear control) in whole cell lysate, mitochondrial fraction (mito), cytosolic fraction (cyto), and nuclear fraction (nucl). (D, E) Quantification of ARH3 expression of V335G mutant relative to control (cntr: healthy individual) per fraction normalized to the respective subcellular fraction control α-tubulin/H3/α-tubulin/VDAC1 showing (n = 4, mean and SD) (E) quantification of panADPr signal of V335G mutant relative to control (cntr: healthy individual) per fraction normalized to the respective subcellular fraction control α-tubulin/H3 (n = 4, mean and SD).

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1. ARH3 antibody specificity in U2OS knock-out model.

    Western blot of whole cell lysates of WT and ARH3-KO U2OS cell lines showing the specificity of the ARH3 antibody (sc-374162; Santa Cruz) with α-tubulin as a loading control.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Live cell imaging of U2OS overexpression model.

    Localization of ARH3 protein as checked by live cell imaging for GFP-tagged ARH3 (green) with mitotracker (red) and Hoechst (blue) staining in separate and merged images in ARH3(WT)-GFP wild-type and mutants D77N D78N (catalytic null) and V335G in transfected U2OS cells. Size bar indicates 10 µm.

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2. Live cell imaging of U2OS overexpression model.

    (A) Localization of ARH3 protein as checked by live cell imaging for GFP-tagged ARH3 (green) with mitotracker (red) and DAPI (blue) staining in separate and merged images in ARH3(WT)-GFP, ARH3(CAT)-GFP, and ARH3(V335G)-GFP in transfected BE(2)-M17 neuroblastoma cells. Size bar indicates 10 µm. (B) Recruitment of ARH3-GFP to the nucleus and DNA damage sites (white arrows) upon laser-induced DNA damage. The ARH3(V335G)-GFP protein does not relocate upon laser-induced DNA damage. (C) Expression of ARH3(WT)-GFP and ARH3(V335)-GFP protein in transfected U2OS cells. Size bar indicates 10 µm.

  • Figure S3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S3. H2O2 induces panADPr signal in control (cntr) and mutant V335G cells.

    Western blot of whole cell lysates of wild-type (cntr: healthy individual) and V335G mutant fibroblast cell lines showing the up-regulation of panADPr signal in presence of 2 mM H2O2 stimulation (+) as compared with non-stimulated conditions (−), with HSP60 as a loading control.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5. Recruitment of ARH3 to DNA damage site.

    (A) Subcellular fractions of patient (V335G) and control (cntr: healthy individual) fibroblasts treated with H2O2 to induce DNA damage, immunoblotted for α-tubulin (cytosolic control), H3 (nuclear control) and VDAC1 (mitochondrial control) in whole cell lysate, nuclear fraction (nucl), cytosolic fraction (cyto) and mitochrondial fraction (mito). (B, C) Quantification of ARH3 expression of V335G mutant relative to control (cntr: healthy individual) per fraction normalized to the respective subcellular fraction control α-tubulin/H3/α-tubulin/VDAC1 (n = 4, mean and SD) (C) quantification of panADPr signal of V335G mutant relative to control (cntr: healthy individual) per fraction normalized to the respective subcellular fraction control α-tubulin/H3 (n = 4, mean and SD).

Tables

  • Figures
    • View popup
    Table 1.

    Clinical description of patients carrying homozygous ADPRHL2 missense variants showing variable phenotypes.

    IndividualA:II:1 (patient 1)A:II:2 (patient 2)B:II:1 (patient 3)
     GenderMMF
     Parental consanguinityReported negativeReported negative+
     Current age or age at death34 yr32 yra16 yra
     Circumstances of death—Cardiac arrest/respiratory failureRespiratory failure
    ADPRHL2 Mutation
     Genomic position (hg19)Chr1: 36558899T>GChr1: 36558899T>GChr1: 36554582G>T
     cDNANM_017825: c.1004T>GNM_017825: c.1004T>GNM_017825: c.77G>T
     Proteinp.Val335Glyp.Val335Glyp.Cys26Phe
    Clinical features
     Age at onset13 yr15 yr15 mo
     Symptoms at onsetWalking instability and intermittent lateropulsionFatigue and instability during walkingFebrile seizures
     Psychomotor developmentNormalNormalNormal speech, moderate intellectual disability (6 yr)
     General developmentNormalNormalGrowth retardation for which growth hormones were supplied
     GaitWeakness of foot dorsiflexors, drop foot, and mild spasticityFoot dorsiflexor weakness, drop foot, mild spasticity, and instability; later also affected by fractureWeakness of foot dorsiflexors, drop foot
     Muscle atrophyModerate atrophy of distal third of upper and lower limbsModerate atrophy of distal upper and lower limbs and mild proximal atrophyModerate atrophy of intrinsic hand muscles (10 yr), mild atrophy of distal lower limbs
     Proximal strength upper limb555
     Distal strength upper limb42–42/5 to 4-/5
     Proximal strength lower limb555
     Distal strength lower limb1–21–34-/5 to 5/5
     Reflexes upper limbNormalDiminishedNormal
     Reflexes lower limbNormalDistally diminishedNormal
     Sensory involvementHypoesthesia in tip toes, deep position, and vibration sense severely diminished in lower legs and handsHypoesthesia and loss of vibration sense in legs-
     Seizure type-Myoclonic jerksFebrile seizures
     Cardiac featuresNormalNormalLeft ventricle hypertrophy and mitral insufficiency
     Other clinical featuresMotor tics in childhood, micrognathia, nystagmus, postural tremor, absent trunk hair, pes cavus, mild to moderately restrictive pulmonary function, and scoliosisNystagmus, postural tremor, mild dysarthria, pes cavus, hyperhidrosis, absent trunk hair, carpal tunnel surgery, and mixed restrictive/obstructive lung functionModerate scoliosis, growth retardation, pes cavus, and exostosis with confirmed causal EXT1 variant
    Neurological examination
     EMGSevere axonal motor polyneuropathy and mild sensory involvementSevere axonal motor polyneuropathy and mild sensory involvementProfound axonal motor polyneuropathy, no sensory involvement
     Brain MRI (age performed)Normal (13 yr)Normal (26 yr)Normal (13 yr)
    Mild white matter hyperintensity lesions (33 yr)
     EEGNormalMild nonspecific changes with intermittent bifrontal theta wavesSporadic epileptiform activity frontocentral localization
     Other genetic features--NM_000127.2 (EXT1): c.538_539delAG (p.Leu181Profs)
    • a Individual is deceased

PreviousNext
Back to top
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
ADPRHL2 mutations affect DNA damage response
Danique Beijer, Thomas Agnew, Johannes Gregor Matthias Rack, Evgeniia Prokhorova, Tine Deconinck, Berten Ceulemans, Stojan Peric, Vedrana Milic Rasic, Peter De Jonghe, Ivan Ahel, Jonathan Baets
Life Science Alliance Sep 2021, 4 (11) e202101057; DOI: 10.26508/lsa.202101057

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ADPRHL2 mutations affect DNA damage response
Danique Beijer, Thomas Agnew, Johannes Gregor Matthias Rack, Evgeniia Prokhorova, Tine Deconinck, Berten Ceulemans, Stojan Peric, Vedrana Milic Rasic, Peter De Jonghe, Ivan Ahel, Jonathan Baets
Life Science Alliance Sep 2021, 4 (11) e202101057; DOI: 10.26508/lsa.202101057
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 4, No. 11
November 2021
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Genetics, Gene Therapy & Genetic Disease
  • Neuroscience

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Chromatin context-dependent interferon response
  • DKC1 in tumor metabolism and metastasis
  • Complex interplay between PMD and MORC1 silencing pathways
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2023 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.